Delivery Order SPE2DB22D3501-SPE2DB25FUS40
Award Date
2/26/25
Potential Completion Date
2/27/25
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,968.55 Firm Fixed Price delivery order contract is for the supply of Abiraterone Acetate 500 mg tablets, a medication used in the treatment of prostate cancer. The contract has an ultimate completion date of January 13, 2025 and is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999...
This federal contract award, valued at $73,068.85, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of abiraterone acetate 500 mg tablets, a medication used in the treatment of prostate cancer. The contract is a Firm Fixed Price Delivery Order that runs through January 15, 2025. It is not associated with a set-aside program. AmerisourceBergen holds a larger...
This federal contract award, valued at $10,423.75, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Abiraterone Acetate 500 mg tablets, a medication used to treat prostate cancer. This contract is not designated as a set-aside, indicating open competition. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This federal contract award, valued at $2,275.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 120 tablets of 250 mg Abiraterone Acetate, a medication used in the treatment of prostate cancer. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of December 21, 2023. It is not designated as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,733.10, is for the delivery of 4,567,313,202 units of abiraterone acetate 250 mg tablets. The contract is a delivery order with a firm fixed price, and the ultimate completion date is February 20, 2025. This contract award is not designated as a set-aside contract. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,197.04 Firm Fixed Price delivery order is for the supply of 4,557,943,655 tablets of Abiraterone Acetate 250 mg, a medication used to treat prostate cancer. The contract has an ultimate completion date of August 1, 2022 and was awarded on July 29, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,402.91, is a Firm Fixed Price Delivery Order for the supply of Abiraterone Acetate 500 mg tablets. The contract has an ultimate completion date of February 14, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,822.78 firm fixed price delivery order is for the supply of 4565133468 Abiraterone Acetate 250 mg tablets. The contract has a ceiling value of $1,822.78 and a completion date of July 15, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,747.20, is for the delivery of abiraterone acetate 250 mg tablets. It is a firm fixed-price delivery order contract with a completion date of February 21, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Abiraterone Acetate 250 mg tablets. The contract, valued at $94,299.16, has a period of performance through January 8, 2025 and utilizes a firm fixed-price pricing type. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that maintains a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...